Immunotherapy Drugs

Melanoma patients benefit from immunotherapy drug: Study

Sep 20, 2021

According to the results of an international, randomised phase III clinical trial led by UPMC Hillman Cancer Center, immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma.

Recent News

10 minutes ago

Two people arrested for offensive conduct after NPL final match

22 minutes ago

President administers oath of office to five ambassadors-designate

7 hours ago

Fog in Terai, snowfall likely in high hills

8 hours ago

Forex: US dollar stable, other currencies rise

8 hours ago

Kathmandu's minimum temperature continues to drop

Reception in honour of President Paudel in Berlin

Nepal defeated by Bangladesh

Landslide obstructs Muglin-Malekhu road section

Nepal's First Online News Portal

Published by Nepalnews Pvt Ltd
Editor: Raju Silwal
Information Department Registration No. 1505 / 076-77

Contact

Kathmandu, Nepal,

Newsroom
##

E-mail
nepalnewseditor@gmail.com

Social Media

Facebook

Instagram

Twitter

Youtube

Exploration

About Us

Privacy Policy

Archive